255 related articles for article (PubMed ID: 9370177)
1. Mesangial phenotypic changes associated with cellular lesions in primary focal segmental glomerulosclerosis.
Hattori M; Horita S; Yoshioka T; Yamaguchi Y; Kawaguchi H; Ito K
Am J Kidney Dis; 1997 Nov; 30(5):632-8. PubMed ID: 9370177
[TBL] [Abstract][Full Text] [Related]
2. A quantitative analysis of the glomeruli in focal segmental glomerulosclerosis.
Suzuki J; Yoshikawa N; Nakamura H
Pediatr Nephrol; 1994 Aug; 8(4):416-9. PubMed ID: 7947029
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
Cho MH; Hong EH; Lee TH; Ko CW
Nephrology (Carlton); 2007 Dec; 12 Suppl 3():S11-4. PubMed ID: 17995521
[TBL] [Abstract][Full Text] [Related]
4. Synaptopodin expression in idiopathic nephrotic syndrome of childhood.
Srivastava T; Garola RE; Whiting JM; Alon US
Kidney Int; 2001 Jan; 59(1):118-25. PubMed ID: 11135064
[TBL] [Abstract][Full Text] [Related]
5. Podocin and uPAR are good biomarkers in cases of Focal and segmental glomerulosclerosis in pediatric renal biopsies.
Pereira LHM; da Silva CA; Monteiro MLGDR; Araújo LS; Rocha LP; Reis MBDR; Ramalho FS; Corrêa RRM; Silva MV; Reis MA; Machado JR
PLoS One; 2019; 14(6):e0217569. PubMed ID: 31188898
[TBL] [Abstract][Full Text] [Related]
6. The nonspecificity of focal segmental glomerulosclerosis. The defining characteristics of primary focal glomerulosclerosis, mesangial proliferation, and minimal change.
McAdams AJ; Valentini RP; Welch TR
Medicine (Baltimore); 1997 Jan; 76(1):42-52. PubMed ID: 9064487
[TBL] [Abstract][Full Text] [Related]
7. HIV-associated nephropathy: experimental models.
Avila-Casado C; Fortoul TI; Chugh SS
Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
[TBL] [Abstract][Full Text] [Related]
8. Posttransplantation relapse of FSGS is characterized by glomerular epithelial cell transdifferentiation.
Bariéty J; Bruneval P; Hill G; Irinopoulou T; Mandet C; Meyrier A
J Am Soc Nephrol; 2001 Feb; 12(2):261-274. PubMed ID: 11158216
[TBL] [Abstract][Full Text] [Related]
9. Reversible glomerular hypertrophy in adult patients with primary focal segmental glomerulosclerosis.
Nishimoto K; Shiiki H; Nishino T; Uyama H; Iwano M; Dohi K
J Am Soc Nephrol; 1997 Nov; 8(11):1668-78. PubMed ID: 9355069
[TBL] [Abstract][Full Text] [Related]
10. Reduced INF2 expression in nephrotic syndrome is possibly related to clinical severity of steroid resistance in children.
Tamura H; Nakazato H; Kuraoka S; Yoneda K; Takahashi W; Endo F
Nephrology (Carlton); 2016 Jun; 21(6):467-75. PubMed ID: 26383224
[TBL] [Abstract][Full Text] [Related]
11. Podocytes are the major source of IL-1 alpha and IL-1 beta in human glomerulonephritides.
Niemir ZI; Stein H; Dworacki G; Mundel P; Koehl N; Koch B; Autschbach F; Andrassy K; Ritz E; Waldherr R; Otto HF
Kidney Int; 1997 Aug; 52(2):393-403. PubMed ID: 9263995
[TBL] [Abstract][Full Text] [Related]
12. Significance of early phenotypic change of glomerular podocytes detected by Pax2 in primary focal segmental glomerulosclerosis.
Ohtaka A; Ootaka T; Sato H; Soma J; Sato T; Saito T; Ito S
Am J Kidney Dis; 2002 Mar; 39(3):475-85. PubMed ID: 11877566
[TBL] [Abstract][Full Text] [Related]
13. Detection of activated parietal epithelial cells on the glomerular tuft distinguishes early focal segmental glomerulosclerosis from minimal change disease.
Smeets B; Stucker F; Wetzels J; Brocheriou I; Ronco P; Gröne HJ; D'Agati V; Fogo AB; van Kuppevelt TH; Fischer HP; Boor P; Floege J; Ostendorf T; Moeller MJ
Am J Pathol; 2014 Dec; 184(12):3239-48. PubMed ID: 25307344
[TBL] [Abstract][Full Text] [Related]
14. The significance of glomerular hypertrophy in focal segmental glomerulosclerosis.
Lee HS; Lim SD
Clin Nephrol; 1995 Dec; 44(6):349-55. PubMed ID: 8719545
[TBL] [Abstract][Full Text] [Related]
15. Electron microscopic findings suggestive of focal and segmental glomerulosclerosis in patients with steroid-resistant nephrotic syndrome.
Nili F; Saboori F; Jahanzad I; Mehrazma M
Ultrastruct Pathol; 2019; 43(1):6-12. PubMed ID: 30835594
[TBL] [Abstract][Full Text] [Related]
16. Glomerular hypertrophy in preeclamptic patients with focal segmental glomerulosclerosis. A morphometric analysis.
Nishimoto K; Shiiki H; Nishino T; Kimura T; Sasaki Y; Yamasaki M; Morikawa H; Fujimoto S; Dohi K
Clin Nephrol; 1999 Apr; 51(4):209-19. PubMed ID: 10230553
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of podocyte phenotype in idiopathic collapsing glomerulopathy and HIV-associated nephropathy.
Yang Y; Gubler MC; Beaufils H
Nephron; 2002 Jul; 91(3):416-23. PubMed ID: 12119471
[TBL] [Abstract][Full Text] [Related]
18. Minimal change disease and idiopathic focal segmental glomerulosclerosis in adults. A quantitative study.
Danilewicz M; Wagrowska-Danilewicz M
Pol J Pathol; 1996; 47(4):209-14. PubMed ID: 9097714
[TBL] [Abstract][Full Text] [Related]
19. Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathy.
Morita M; Mii A; Shimizu A; Yasuda F; Shoji J; Masuda Y; Ohashi R; Nagahama K; Kaneko T; Tsuruoka S
PLoS One; 2015; 10(4):e0116700. PubMed ID: 25875837
[TBL] [Abstract][Full Text] [Related]
20. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
Stokes MB; Markowitz GS; Lin J; Valeri AM; D'Agati VD
Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
